118 related articles for article (PubMed ID: 38878214)
1. Prostaglandin I
Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G
Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214
[TBL] [Abstract][Full Text] [Related]
2. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
[TBL] [Abstract][Full Text] [Related]
3. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.
Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL
Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239
[TBL] [Abstract][Full Text] [Related]
4. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
5. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
Jiang XX; Zhang R; Wang HS
Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
[TBL] [Abstract][Full Text] [Related]
6. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
7. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
[TBL] [Abstract][Full Text] [Related]
8. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.
Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y
Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
10. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
12. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.
Song S; Zhang R; Mo B; Chen L; Liu L; Yu Y; Cao W; Fang G; Wan Y; Gu Y; Wang Y; Li Y; Yu Y; Wang Q
J Mol Cell Cardiol; 2019 Oct; 135():119-133. PubMed ID: 31408621
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
Cao F; Li Z; Ding WM; Yan L; Zhao QY
Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
[TBL] [Abstract][Full Text] [Related]
16. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice.
Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ
Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling.
Tsai CT; Lai LP; Kuo KT; Hwang JJ; Hsieh CS; Hsu KL; Tseng CD; Tseng YZ; Chiang FT; Lin JL
Circulation; 2008 Jan; 117(3):344-55. PubMed ID: 18172037
[TBL] [Abstract][Full Text] [Related]
18. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
Wu Y; Can J; Hao S; Qiang X; Ning Z
Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
[TBL] [Abstract][Full Text] [Related]
19. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
Ma J; Ma S; Yin C; Wu H
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
